ArticleJournal of experimental & clinical cancer research : CR2017

FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.

Lixia Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.